Rachel Nash

A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)

Usha Chakravarthy, Simon Harding, Chris Rogers et al. · Health Technology Assessment · 2015 · 98 citations · Full text

Medicine, Pharmacoeconomics, Pharmacology +14

High levels of polo-like kinase 1 and phosphorylated translationally controlled tumor protein indicate poor prognosis in neuroblastomas

Pramila Ramani, Rachel Nash, Emile Sowa‐Avugrah et al. · Journal of Neuro-Oncology · 2015 · 56 citations

Medicine, Cancer Biology, Oncology +12

Aurora kinase A is superior to Ki67 as a prognostic indicator of survival in neuroblastoma

Pramila Ramani, Rachel Nash, Chris Rogers · Histopathology · 2014 · 55 citations

Medicine, Oncology, Pathology +15

A multicentre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2)

Barnaby C Reeves, Katie Pike, Chris Rogers et al. · Health Technology Assessment · 2016 · 47 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

Propofol cardioplegia: A single-center, placebo-controlled, randomized controlled trial

Chris Rogers, Alan J. Bryan, Rachel Nash et al. · Journal of Thoracic and Cardiovascular Surgery · 2015 · 24 citations · Full text

Medicine, Anesthesiology, Surgery +11